Principal Healthcare Innovators Index ETF (BTEC) Alternatives
Principal Healthcare Innovators Index ETF (BTEC) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with BTEC. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.
Cheapest Alternatives to BTEC
BTEC charges 0.42% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among BTEC alternatives.
| Symbol | Name | Expense Ratio | Inception | |
|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | 0.08% | Oct 21, 2013 | BTEC vs FHLC | |
| State Street Health Care Select Sector SPDR ETF | 0.08% | Dec 16, 1998 | BTEC vs XLV | |
| Vanguard Health Care ETF | 0.10% | Jan 26, 2004 | BTEC vs VHT | |
| Invesco S&P SmallCap Health Care ETF | 0.29% | Apr 7, 2010 | BTEC vs PSCH | |
| SPDR S&P Pharmaceuticals ETF | 0.35% | Jun 19, 2006 | BTEC vs XPH |
Best Risk-Adjusted Alternatives to BTEC
Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.
| Symbol | Name | Risk / Return Rank | Inception | |
|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 97 | Dec 16, 2014 | BTEC vs BBC | |
| ALPS Medical Breakthroughs ETF | 95 | Dec 31, 2014 | BTEC vs SBIO | |
| SPDR S&P Biotech ETF | 92 | Feb 6, 2006 | BTEC vs XBI | |
| Tema Oncology ETF | 90 | Aug 14, 2023 | BTEC vs CANC | |
| F/m Emerald Life Sciences Innovation ETF | 86 | Oct 30, 2024 | BTEC vs LFSC |
Top Performing BTEC Alternatives (YTD)
BTEC alternatives from the Health & Biotech Equities category, sorted by year-to-date return.
| Symbol | Name | YTD Return | Inception | |
|---|---|---|---|---|
| iShares Genomics Immunology and Healthcare ETF Gen... | 10.92% | Jun 11, 2019 | BTEC vs IDNA | |
| Virtus LifeSci Biotech Clinical Trials ETF | 7.95% | Dec 16, 2014 | BTEC vs BBC | |
| Tema Oncology ETF | 5.69% | Aug 14, 2023 | BTEC vs CANC | |
| SPDR S&P Biotech ETF | 4.76% | Feb 6, 2006 | BTEC vs XBI | |
| First Trust Nasdaq Pharmaceuticals ETF | 4.48% | Sep 20, 2016 | BTEC vs FTXH |
Lowest Volatility Alternatives to BTEC
BTEC alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.
| Symbol | Name | Volatility 1Y | Inception | |
|---|---|---|---|---|
| Loncar Cancer Immunotherapy ETF | 0.00% | Oct 13, 2015 | BTEC vs CNCR | |
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | BTEC vs GERM | |
| Horizon Kinetics SPAC Active ETF | 8.60% | Jun 29, 2007 | BTEC vs SPAQ | |
| Global X Aging Population ETF | 15.94% | May 9, 2016 | BTEC vs AGNG | |
| Jpmorgan Healthcare Leaders ETF | 17.04% | Nov 1, 2023 | BTEC vs JDOC |
Lowest Drawdown Alternatives to BTEC
BTEC alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.
| Symbol | Name | Max Drawdown 1Y | Inception | |
|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | BTEC vs GERM | |
| Horizon Kinetics SPAC Active ETF | -5.30% | Jun 29, 2007 | BTEC vs SPAQ | |
| Jpmorgan Healthcare Leaders ETF | -9.68% | Nov 1, 2023 | BTEC vs JDOC | |
| VanEck Vectors Pharmaceutical ETF | -10.02% | Dec 20, 2011 | BTEC vs PPH | |
| Global X Aging Population ETF | -10.16% | May 9, 2016 | BTEC vs AGNG |
Other ETFs from Principal
Most popular Principal ETFs on PortfoliosLab, across asset classes.
Often Compared With BTEC
What investors most often compare with BTEC, based on PortfoliosLab usage data.
Compare BTEC with Any Fund or Stock
Compare BTEC with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.